Pulmonary Rehabilitation and Smoking

Effectiveness of Pulmonary Rehabilitation in Smoker Patients With COPD

Pulmonary rehabilitation (PR) is known to reduce dyspnea, increase exercise capacity, reduce psychological symptoms and improve quality of life in COPD patients. Some patients continue to smoke despite their illness. Smoking does not create a contraindication to PR. There is insufficient evidence on the effectiveness of PR programs in smoking COPD patients. The purpose of this study, PR completed the program to determine the effectiveness of PR smoker COPD patients.

Study Overview

• Status: Completed
• Conditions: Smoking; Rehabilitation; Tobacco Use
• Intervention / Treatment: Other: Exercise

Detailed Description

Pulmonary rehabilitation (PR) is known to reduce dyspnea, increase exercise capacity, reduce psychological symptoms and improve quality of life in COPD patients. Some patients continue to smoke despite their illness. Smoking does not create a contraindication to PR. There is insufficient evidence on the effectiveness of PR programs in smoking COPD patients. The purpose of this study, PR completed the program to determine the effectiveness of PR smoker COPD patients. People who have completed the PR program, smoking and not smoking will be included into the study.

Data of carbon monoxide diffusion test, body plethysmography, 6-min walk test, blood gas analysis, mMRC dyspnea scale, hospital anxiety depression scale, SGRQ and SF-36 quality of life questionnaire performed before and after the program will be analyzed.

• Study Type: Interventional
• Enrollment (Actual): 31
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• COPD patients completed 8 PR program

Exclusion Criteria:

• Never smoked patients
• Participated PR program in last year

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Smoking; 8 week exercise program consists of breathing exercises, strength training and endurance training	Other: Exercise; 8 week exercise program
Experimental: Ex- Smoking; 8 week exercise program consists of breathing exercises, strength training and endurance training	Other: Exercise; 8 week exercise program

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Six minute walk test	It was performed in a 30-meter long corridor in accordance with American Thoracic	6 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pulmonary Function Test	It was used for assessment of lung functions	20 minutes
Dyspnea Severity	MMRC Dyspnea Scale (0: no dyspnea, 4: very severe dyspnea), It was used for dyspnea that patients felt during their daily activities.	5 minues
St. George Disease Related Quality of Life Scale	A disease-specific quality of life scale (Max. score:100, lower score means better quality of life level)	20 minutes
Short Form-36 Quality of Life Survey	A health related quality of life scale, Short Form-36 Quality of Life Survey (Max. score:100, higher score means better quality of life level)	25 minutes
Hospital Anxiety and Depression Inventory	It was used for assessment of anxiety and depression	20 minutes

Collaborators and Investigators

• Sponsor: Izmir Katip Celebi University

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2015
• Primary Completion (Actual): August 1, 2018
• Study Completion (Actual): August 1, 2018

Study Registration Dates

• First Submitted: September 12, 2018
• First Submitted That Met QC Criteria: September 12, 2018
• First Posted (Actual): September 14, 2018

Study Record Updates

• Last Update Posted (Actual): September 17, 2018
• Last Update Submitted That Met QC Criteria: September 13, 2018
• Last Verified: September 1, 2018

More Information

Terms related to this study

• Other Study ID Numbers: ikçü (Other Identifier: Katip Çelebi University)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No